172 related articles for article (PubMed ID: 20816832)
1. Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease.
Glaab T; Taube C
Pulm Pharmacol Ther; 2011 Feb; 24(1):15-22. PubMed ID: 20816832
[TBL] [Abstract][Full Text] [Related]
2. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
3. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
Cave AC; Hurst MM
Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids in COPD: a controversy.
Barnes PJ
Respiration; 2010; 80(2):89-95. PubMed ID: 20501985
[TBL] [Abstract][Full Text] [Related]
5. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
Antón E
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):25-32. PubMed ID: 23551021
[TBL] [Abstract][Full Text] [Related]
6. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
Selroos O
Curr Med Res Opin; 2004 Oct; 20(10):1579-93. PubMed ID: 15462691
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
Sin DD; Man SF
Proc Am Thorac Soc; 2006 Sep; 3(7):624-9. PubMed ID: 16963545
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroids for chronic obstructive pulmonary disease.
Cazzola M; Rogliani P; Novelli L; Matera MG
Expert Opin Pharmacother; 2013 Dec; 14(18):2489-99. PubMed ID: 24138334
[TBL] [Abstract][Full Text] [Related]
9. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease.
Herth FJ; Bramlage P; Müller-Wieland D
Respiration; 2015; 89(1):66-75. PubMed ID: 25471093
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
13. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
López-Campos JL; Calero Acuña C
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
15. Common lung conditions: chronic obstructive pulmonary disease.
Delzell JE
FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
[TBL] [Abstract][Full Text] [Related]
16. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
Nishimura K
Nihon Rinsho; 2003 Dec; 61(12):2181-6. PubMed ID: 14674330
[TBL] [Abstract][Full Text] [Related]
17. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of inhaled corticosteroids in COPD].
Kamoi H; Yoshikawa T; Hirata K
Nihon Rinsho; 2007 Apr; 65(4):696-701. PubMed ID: 17419390
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids in chronic obstructive pulmonary disease.
Suissa S; McGhan R; Niewoehner D; Make B
Proc Am Thorac Soc; 2007 Oct; 4(7):535-42. PubMed ID: 17878466
[TBL] [Abstract][Full Text] [Related]
20. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
Gillissen A; Gessner C; Hoheisel G; Juergens U
Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
